An observational multi-center study to validate outcome measures for future clinical trials of Multiple System Atrophy (MSA)

Go Back to All Clinical Trials

An observational multi-center study to validate outcome measures for future clinical trials of Multiple System Atrophy (MSA)

Brief description of study

The purpose of this research study is to develop and validate new methods to measure if a potential drug being tested in future clinical trials of patients with multiple system atrophy (MSA) is effective. These methods include a scale or questionnaire (“clinical outcome assessment” or COA), brain neuroimaging (magnetic resonance imaging or MRI) and biochemical biomarkers (blood or cerebrospinal fluid (CSF) samples).

Clinical Study Identifier: s21-00939

Principal Investigator: Horacio Kaufmann.

Other Investigators: Patricio Alejandro Millar Vernetti, Thong C Ma, Jose Alberto Palma Carazo, Timothy Michael Shepherd, Un Kang.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies